162 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
51 | 12492611 | Quantification of heparin-induced TFPI release: a maximum release at low heparin dose. | 2002 Dec | 9 |
52 | 12714831 | Comparative effects of unfractionated heparin and low molecular weight heparin on vascular endothelial cell tissue factor pathway inhibitor release: a model for assessing intrinsic thromboresistance. | 2002 Oct | 8 |
53 | 11229821 | Elevated levels of free tissue factor pathway inhibitor antigen in cases of disseminated intravascular coagulation caused by various underlying diseases. | 2001 Jan | 1 |
54 | 11254842 | Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor. | 2001 Feb | 3 |
55 | 11372675 | Plasma levels of total and free tissue factor pathway inhibitor (TFPI) as individual pharmacological parameters of various heparins. | 2001 May | 9 |
56 | 11380428 | Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis. | 2001 May | 3 |
57 | 11434705 | The effect of unfractionated vs. low molecular weight heparin on tissue factor pathway inhibitor levels in hospital inpatients. | 2001 Jun | 10 |
58 | 11441984 | Tissue factor pathway inhibitor release induced by defibrotide and heparins. | 2001 Jul | 3 |
59 | 11457474 | Endogenous release of tissue factor pathway inhibitor by topical application of an ointment containing mucopolysaccharide polysulfate to nonhuman primates. | 2001 Jul 15 | 4 |
60 | 11668420 | Molecular weight-dependent influence of heparin on the form of tissue factor pathway inhibitor circulating in plasma. | 2001 Oct | 14 |
61 | 11709459 | Changes in the concentration and distribution of tissue factor pathway inhibitor in Behçet's disease and systemic lupus erythematosus: effect on the prethrombotic state. | 2001 Dec | 2 |
62 | 11772296 | Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders. | 2001 Nov | 3 |
63 | 11776326 | Bemiparin and fluid flow modulate the expression, activity and release of tissue factor pathway inhibitor in human endothelial cells in vitro. | 2001 Dec | 4 |
64 | 10664333 | Altered plasma antigen levels of tissue factor pathway inhibitor during open-heart surgery. | 2000 | 3 |
65 | 10847421 | Dose-dependent release of endogenous tissue factor pathway inhibitor by different low molecular weight heparins. | 2000 Jun | 6 |
66 | 10896252 | Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro. | 2000 Jun | 7 |
67 | 10922378 | Tissue factor pathway inhibitor binds to platelet thrombospondin-1. | 2000 Oct 13 | 1 |
68 | 10928482 | Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass. | 2000 Jul | 2 |
69 | 11132652 | In vitro effects of heparin and tissue factor pathway inhibitor on factor VII assays. possible implications for measurements in vivo after heparin therapy. | 2000 Dec | 2 |
70 | 11150580 | Reduction of factor FVIIa activity during heparin therapy. Evidence for assay interactions with tissue factor pathway inhibitor and antithrombin. | 2000 Dec 1 | 5 |
71 | 11251341 | Physiological function of tissue factor pathway inhibitor and interaction with heparins. | 2000 | 8 |
72 | 9974412 | Tissue factor pathway inhibitor is expressed by human monocyte-derived macrophages : relationship to tissue factor induction by cholesterol and oxidized LDL. | 1999 Feb | 2 |
73 | 10063992 | Low levels of heparin-releasable tissue factor pathway inhibitor in young patients with thrombosis. | 1999 Feb | 4 |
74 | 10065895 | Plasma tissue factor pathway inhibitor and tissue factor antigen levels after administration of heparin in patients with angina pectoris. | 1999 Jan 1 | 2 |
75 | 10235445 | Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration. | 1999 Apr | 1 |
76 | 10336236 | Do antiphospholipid antibodies interfere with tissue factor pathway inhibitor? | 1999 May 15 | 3 |
77 | 10397725 | Regulation of tissue factor pathway inhibitor expression in smooth muscle cells. | 1999 Jul 15 | 2 |
78 | 10479670 | Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture. | 1999 Sep | 16 |
79 | 10494757 | High levels of tissue factor pathway inhibitor in patients with nephrotic proteinuria. | 1999 Sep | 2 |
80 | 10545520 | Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor. | 1999 Nov | 1 |
81 | 10606880 | Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins. | 1999 Dec | 2 |
82 | 10613653 | Synthesis and expression of tissue factor pathway inhibitor by serum-stimulated fibroblasts, vascular smooth muscle cells and cardiac myocytes. | 1999 Dec | 2 |
83 | 11938732 | [Affection of aprotinin on tissue factor pathway inhibitor in peri-operation of cardiac direct vision operation]. | 1999 | 3 |
84 | 9622039 | Platelet count, anti-heparin/platelet factor 4 antibodies and tissue factor pathway inhibitor plasma antigen level in chronic dialysis. | 1998 Feb 1 | 1 |
85 | 9622042 | Heparin-releasable endothelial cell-associated tissue factor pathway inhibitor (TFPI) is increased in the coronary circulation after coronary spasm in patients with coronary spastic angina. | 1998 Feb 1 | 5 |
86 | 9622211 | Tissue factor pathway inhibitor and anti-FXa kinetic profiles of a new low-molecular-mass heparin, Bemiparin, at therapeutic subcutaneous doses. | 1998 Mar | 2 |
87 | 9651145 | A kinetic analysis of the interaction of human recombinant tissue factor pathway inhibitor with factor Xa utilizing and immunoassay and the effect of antithrombin III/heparin on the complex formation. | 1998 Feb 15 | 1 |
88 | 9669748 | Structural requirements of human tissue factor pathway inhibitor (TFPI) and heparin for TFPI-heparin interaction. | 1998 Mar 15 | 10 |
89 | 9674734 | Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action. | 1998 Jun | 11 |
90 | 9736420 | Differential effects of low molecular weight heparin and unfractionated heparin on circulating levels of antithrombin and tissue factor pathway inhibitor (TFPI): a possible mechanism for difference in therapeutic efficacy. | 1998 Aug 15 | 8 |
91 | 9778325 | Oral delivery of anticoagulant doses of heparin. A randomized, double-blind, controlled study in humans. | 1998 Oct 20 | 1 |
92 | 9798992 | Fucoidan, as heparin, induces tissue factor pathway inhibitor release from cultured human endothelial cells. | 1998 Oct | 4 |
93 | 9819002 | A supersulfated low-molecular-weight heparin (IK-SSH) increases plasma levels of free and total tissue factor pathway inhibitor after intravenous and subcutaneous administration in humans. | 1998 Sep | 3 |
94 | 10420071 | Efficacy of unfractionated heparin, low molecular weight heparin and both combined for releasing total and free tissue factor pathway inhibitor. | 1998 Sep-Oct | 4 |
95 | 15992020 | Recombinant TFPI and variants: potential implications in the treatment of cardiovascular disorders. | 1998 Jul | 3 |
96 | 9156410 | Tissue factor pathway inhibitor (TFPI) antigen plasma level in patients with interstitial lung disease before and after heparin administration. | 1997 | 4 |
97 | 9187023 | The effect of protamine sulphate on plasma tissue factor pathway inhibitor released by intravenous and subcutaneous unfractionated and low molecular weight heparin in man. | 1997 May 15 | 6 |
98 | 9200336 | Endothelial cell-associated tissue factor pathway inhibitor (TFPI) antigen in severe nondiabetic obese patients: effect of hyperinsulinemia. | 1997 | 2 |
99 | 9345040 | Association of tissue factor pathway inhibitor with human umbilical vein endothelial cells. | 1997 Nov 1 | 1 |
100 | 9359432 | Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor. | 1997 Oct 15 | 1 |